Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics
US Radiology Specialists backer Welsh, Carson, Anderson & Stowe blasted the proposed order Friday, labeling it as symbolic and politically motivated.
Congressional candidate physician sues hospital and doctor for death of father
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
DEA wants to permanently anchor some COVID-era prescription regulations
The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.
FDA regulator examines AI's growing influence in cardiology
Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.
RadNet sees potential midsize and larger acquisitions on its horizon
Leaders with the Los Angeles-based, publicly traded imaging center operator spoke Jan. 15 at the 43rd annual JP Morgan Healthcare Conference in San Francisco.

Abbott pulled the Trifecta GTaortic surgical valve off market in July 2023 after it was determined it had early structural valve deterioration (SVD) before 5 years.

Abbott pulls Trifecta heart valves off the market due to early deterioration

The FDA sent notice today that Abbott is pulling the Trifecta aortic surgical heart valve off the U.S. market due to the risk of early structural valve deterioration in less than 5 years.

ACR estimates diagnostic radiology will face 4% Medicare cut, absent congressional action

The college issued a detailed breakdown of the 2024 MPFS, offering insight into the “complex” formula for how much the specialty stands to lose.

artificial intelligence cybersecurity cybercrime patient data privacy

Imaging AI adds value to patient data but also puts it at heightened risk

Healthcare AI continues its march into clinical departments as well as imaging activities. In the process, it’s only multiplying break-and-entry points seductive to cybercriminals.

EHR nudge helps health system drop use of unnecessary lumbar X-rays by 53%

Researchers with NYC Health + Hospitals detailed their large-scale quality improvement project in the Journal of the American College of Radiology.

artificial intelligence money finance acquisition

RapidAI raises $75M in series C financing

The San Mateo, California-based startup said the money will help it tackle more diseases and add further functions to the company's platform.

GE Healthcare recall TruSignal SpO2 sensors

GE Healthcare recalls certain SpO2 sensors due to risk of serious errors during defibrillation

There is a risk of the devices sending a reduced amount of energy to the heart during defibrillation. More than 7,000 devices are being recalled due to this issue.

FDA announces recall of nearly 8,000 Impella blood pumps due to risk of injury or death in TAVR patients

There have been 30 complaints so far about this issue, including 26 injuries and four deaths.

Abbott recalls delivery sheath for LAA occluder device after 16 injuries

The FDA has categorized this as a Class I recall, which means using the devices “may cause serious injuries or death.”

Management

Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics

Congressional candidate physician sues hospital and doctor for death of father

DEA wants to permanently anchor some COVID-era prescription regulations

FDA regulator examines AI's growing influence in cardiology

RadNet sees potential midsize and larger acquisitions on its horizon